Heyuan Biotech: Net profit approximately -158 million yuan in 2025

2026-02-26 09:20:55

Abstract generation in progress

Mingji AI Express: He Yuan Biotechnology released its 2025 performance forecast on the evening of February 26, reporting operating revenue of 47.8614 million yuan, an increase of 89.8% year-on-year; net profit attributable to shareholders of the listed company was a loss of approximately 158 million yuan; basic earnings per share were a loss of 0.56 yuan.

Mingji Headlines (nbdtoutiao)—Over 100,000 people flooded the servers to watch 8 real estate companies compete for “racecourses”: 243 rounds of bidding in 9 hours, with a total transaction value of 23.6 billion yuan! A new record for Guangzhou land price: 85,000 yuan per square meter.

(Reporter Zeng Jianhui)

Disclaimer: The content and data of this article are for reference only and do not constitute investment advice. Please verify before use. Proceed at your own risk.

Daily Economic News

View Original

This page may contain third-party content, which is provided for information purposes only (not representations/warranties) and should not be considered as an endorsement of its views by Gate, nor as financial or professional advice. See Disclaimer for details.

1 Likes